🔗 Share this article

This year's prestigious award in medical science has been granted for transformative discoveries that clarify how the body's defense network attacks dangerous infections while sparing the body's own cells.

Three esteemed researchers—from Japan Shimon Sakaguchi and American scientists Dr. Brunkow and Dr. Ramsdell—received this accolade.

The work uncovered specialized "sentinels" within the immune system that eliminate malfunctioning immune cells that could harming the organism.

The discoveries are now paving the way for new treatments for immune disorders and malignancies.

These laureates will divide a prize fund worth 11m Swedish kronor.

Decisive Findings

"The work has been essential for comprehending how the body's defenses functions and why we do not all suffer from serious autoimmune diseases," commented the chair of the award panel.

This team's studies address a core mystery: In what way does the defense system protect us from numerous invaders while keeping our healthy cells intact?

The immune system employs immune cells that scan for signs of infection, including pathogens and germs it has never encountered.

These cells employ sensors—called recognition units—that are produced by chance in a vast number of variations.

That gives the defense network the capacity to combat a broad range of invaders, but the unpredictability of the mechanism inevitably produces immune cells that can attack the body.

Protectors of the Immune System

Scientists earlier knew that a portion of these harmful defense cells were eliminated in the immune organ—the site where immune cells develop.

The latest Nobel Prize recognizes the identification of regulatory T-cells—described as the immune system's "security guards"—which travel through the body to disarm any immune cells that assault the healthy cells.

We know that this process malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and rheumatoid arthritis.

A Nobel panel stated, "The discoveries have established a novel area of investigation and accelerated the creation of innovative therapies, for instance for cancer and autoimmune diseases."

In malignancies, regulatory T-cells block the body from fighting the growth, so research are focused on reducing their numbers.

For self-attack disorders, experiments are exploring boosting T-reg cells so the organism is no longer being harmed. A comparable approach could also be useful in minimizing the risks of organ transplant rejection.

Pioneering Studies

Prof Sakaguchi, of a Japanese institution, performed experiments on rodents that had their thymus extracted, causing self-attack conditions.

The researcher showed that introducing defense cells from healthy animals could stop the illness—suggesting there was a mechanism for blocking immune cells from harming the body.

Mary Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Fred Ramsdell, currently at a biotech firm in San Francisco, were investigating an genetic autoimmune disease in rodents and people that led to the discovery of a genetic factor vital for how T-regs function.

"Their groundbreaking work has uncovered how the body's defenses is controlled by T-reg cells, preventing it from mistakenly attacking the healthy cells," said a leading physiology expert.

"The work is a remarkable example of how fundamental physiological research can have broad consequences for public health."